- Home
- EDSA vs UGRO Comparison
EDSA vs UGRO Comparison
Compare EDSA & UGRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- UGRO
- Stock Information
- Founded
- EDSA 2015
- UGRO 2014
- Country
- EDSA Canada
- UGRO United States
- Employees
- EDSA N/A
- UGRO N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- UGRO Industrial Specialties
- Sector
- EDSA Health Care
- UGRO Consumer Discretionary
- Exchange
- EDSA Nasdaq
- UGRO Nasdaq
- Market Cap
- EDSA 13.8M
- UGRO 5.5M
- IPO Year
- EDSA N/A
- UGRO N/A
- Fundamental
- Price
- EDSA $2.04
- UGRO $0.30
- Analyst Decision
- EDSA Strong Buy
- UGRO Strong Buy
- Analyst Count
- EDSA 2
- UGRO 1
- Target Price
- EDSA $13.00
- UGRO $3.00
- AVG Volume (30 Days)
- EDSA 14.6K
- UGRO 486.5K
- Earning Date
- EDSA 08-08-2025
- UGRO 07-07-2025
- Dividend Yield
- EDSA N/A
- UGRO N/A
- EPS Growth
- EDSA N/A
- UGRO N/A
- EPS
- EDSA N/A
- UGRO N/A
- Revenue
- EDSA N/A
- UGRO $59,985,138.00
- Revenue This Year
- EDSA N/A
- UGRO N/A
- Revenue Next Year
- EDSA N/A
- UGRO $31.25
- P/E Ratio
- EDSA N/A
- UGRO N/A
- Revenue Growth
- EDSA N/A
- UGRO N/A
- 52 Week Low
- EDSA $1.55
- UGRO $0.26
- 52 Week High
- EDSA $5.59
- UGRO $1.92
- Technical
- Relative Strength Index (RSI)
- EDSA 52.18
- UGRO 37.90
- Support Level
- EDSA $1.99
- UGRO $0.26
- Resistance Level
- EDSA $2.14
- UGRO $0.44
- Average True Range (ATR)
- EDSA 0.12
- UGRO 0.04
- MACD
- EDSA 0.02
- UGRO 0.00
- Stochastic Oscillator
- EDSA 58.62
- UGRO 23.20
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
About UGRO urban-gro Inc.
Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.